7:05 PM
 | 
Aug 25, 2015
 |  BC Extra  |  Politics & Policy

NCCN tool will compare cancer drugs' cost-effectiveness

In October, the National Comprehensive Cancer Network plans to launch a tool to compare the cost-effectiveness of cancer treatments. The tool will incorporate metrics including cost, efficacy, safety, quality of evidence and consistency of evidence.

NCCN initially will evaluate treatments for multiple myeloma (MM) and chronic...

Read the full 214 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >